Related Experiment Video

Updated: May 28, 2026

Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator
06:08

Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator

Published on: May 19, 2023

IGFBP-2 at the interface of growth and metabolism--implications for childhood obesity

Matthew A Sabin1, Vincenzo C Russo, Walid J Azar

  • 1Centre for Hormone Research and Department of Endocrinology & Diabetes Murdoch Childrens Research Institute, Royal Children's Hospital and University of Melbourne, Victoria, Australia. matt.sabin@rch.org.au

Pediatric Endocrinology Reviews : PER
|October 7, 2011
PubMed

Insights

Insulin-like growth factor-binding protein-2 (IGFBP-2) plays a key role in childhood growth and metabolism. Lower IGFBP-2 levels are linked to obesity and Type 2 diabetes, suggesting its involvement in weight-related diseases.

Area of Science:

  • Endocrinology
  • Metabolic Research
  • Pediatric Health

Background:

  • The growth hormone/insulin-like growth factor-I (IGF-I) axis regulates childhood growth, with binding proteins modulating IGF-I activity.
  • Insulin-like growth factor-binding protein-2 (IGFBP-2) has demonstrated IGF-I-independent actions, particularly in relation to nutritional status and insulin sensitivity.
  • Reduced IGFBP-2 concentrations are observed in obesity and Type 2 diabetes, highlighting its potential metabolic significance.

Purpose of the Study:

  • To explore the associations between IGFBP-2 and obesity in children.
  • To investigate the role of IGFBP-2 in the development of childhood obesity and related metabolic complications.
  • To understand how IGFBP-2 influences metabolism for potential improvements in obesity prevention and treatment.

Main Methods:

  • Review of existing literature on IGFBP-2, childhood growth, and metabolic health.
  • Analysis of studies linking IGFBP-2 concentrations to nutritional status, obesity, and insulin sensitivity.
  • Exploration of the molecular mechanisms underlying IGFBP-2's role in metabolism and weight regulation.

Main Results:

  • IGFBP-2 is a major binding protein in infancy and produced by adipocytes, positioning it centrally in nutrition, growth, and metabolism.
  • Lower IGFBP-2 levels are consistently found in individuals with obesity and Type 2 diabetes.
  • IGFBP-2 is implicated in the molecular processes driving obesity development and associated diseases.

Conclusions:

  • IGFBP-2 is a critical factor linking nutrition, growth, and metabolism, particularly in childhood.
  • Understanding IGFBP-2's role in metabolism may offer new avenues for preventing and treating childhood obesity.
  • Further research into IGFBP-2 could elucidate pathways for managing weight-related health issues in pediatric populations.

More Related Videos

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis08:34

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis

Published on: June 3, 2016

Segmentation and Measurement of Fat Volumes in Murine Obesity Models Using X-ray Computed Tomography13:09

Segmentation and Measurement of Fat Volumes in Murine Obesity Models Using X-ray Computed Tomography

Published on: April 4, 2012

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Regulation of Food Intake01:30

Regulation of Food Intake

Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Regulation of Metabolism01:19

Regulation of Metabolism

Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.